M. Schuijer

TP53 and ovarian cancer

E. Berns, M. Schuijer, 2003, Human mutation.

Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.

Dick M. Goedhart, P. Serruys, K. Kuck, 2010, Journal of the American College of Cardiology.

TP53 and ovarian cancer

E. Berns, M. Schuijer, 2003, Human mutation.

5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.

Antonio Colombo, Pascal Vranckx, Patrick W Serruys, 2010, Journal of the American College of Cardiology.

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II.

P. Serruys, C. Stefanadis, M. Morice, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.

P. Serruys, R. V. van Domburg, M. Morice, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Ovarian cancer: genetic features and prognostic implications

M. Schuijer, 2000 .